Heart Failure but Not Myocardial Infarction Is Causing Bone Loss in Rodent Models in an FGF23-Independent Manner

Svetlana Slavic1,2,3,4,5, Nejla Latic2, Norbert Hassler1

  • 1Ludwig Boltzmann Institute of Osteology, Heinrich-Collin-Strasse 30, 1140 Vienna, Austria.

Insights

Myocardial infarction (MI) and heart failure (HF) cause bone loss, but only HF induced by transverse aortic constriction (TAC) led to reduced bone mineral density (BMD) in mice, independently of FGF23.

Area of Science:

  • Cardiovascular Biology
  • Bone Metabolism
  • Translational Medicine

Background:

  • Myocardial infarction (MI) and heart failure (HF) are linked to decreased bone mineral density (BMD).
  • The direct causal relationship between cardiac injury and bone loss remains unclear.
  • Investigating specific cardiac conditions and their impact on bone is crucial for understanding comorbidities.

Purpose of the Study:

  • To determine if MI and HF directly induce bone loss.
  • To differentiate the skeletal effects of MI versus pressure-overload HF.
  • To explore the role of FGF23 in cardiac injury-induced bone changes.

Main Methods:

  • Induction of terminal MI in mice via coronary ligation.
  • Myocardial ischemia-reperfusion (I/R) injury in young and aged rats.
  • Transverse aortic constriction (TAC) in wild-type, Fgf23/VDR double mutant, and VDR-deficient mice.
  • Bone phenotyping using pQCT, histomorphometry, and biochemical analyses.

Main Results:

  • MI, in both terminal ischemia and I/R models, did not alter BMD in mice or rats.
  • TAC significantly reduced femoral cortical BMD in mice.
  • FGF23 deficiency did not prevent TAC-induced bone loss, indicating an FGF23-independent mechanism.

Conclusions:

  • Pressure-overload heart failure (HF) induced by TAC causes significant bone loss, particularly affecting cortical bone.
  • Myocardial infarction (MI) does not appear to directly cause bone loss in these models.
  • The bone loss associated with TAC-induced HF is independent of FGF23 signaling.